Standout Papers

Vemurafenib: the first drug approved for BRAF-mutant cancer 2012 2026 2016 2021 579
  1. Vemurafenib: the first drug approved for BRAF-mutant cancer (2012)
    Gideon Bollag, James Tsai et al. Nature Reviews Drug Discovery

Immediate Impact

2 by Nobel laureates 28 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
Rapid in silico directed evolution by a protein language model with EVOLVEpro
2024 StandoutScience
2 intermediate papers

Works of James Tsai being referenced

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
2010
Crystal Structures of Proto-oncogene Kinase Pim1: A Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma
2005

Author Peers

Author Last Decade Papers Cites
James Tsai 750 1082 236 318 26 1.7k
Frank Wu 986 1319 278 178 36 1.9k
Ahmed A. Samatar 624 1284 138 225 28 1.6k
Leanne Berry 710 1187 264 183 24 1.6k
Lorelei J. Hanson 955 1119 409 222 20 1.8k
Michael D. Pickard 1255 1593 211 208 38 2.1k
Samuel C. Blackman 688 871 257 154 33 1.5k
Y.N. Vashisht Gopal 856 1226 257 148 25 1.8k
Katherine G. Moss 663 1197 212 189 17 1.9k
Alastair J. King 658 1569 133 180 28 2.0k
Elena Ardini 525 1013 326 130 37 1.6k

All Works

Loading papers...

Rankless by CCL
2026